(firstQuint)Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers.

 To healthy volunteers subjects of twenty four(24), following treatments are administered dosing in each period injected wash-out period is a minimum of 7days.

 Treatment A(Test Drug): Vorico Injection 200mg(Voriconazole) for Single Dose Treatment B(Reference Drug): Vfend(R) IV 200mg for Single Dose Pharmacokinetic blood samples are collected up to 24hrs.

 Safety and pharmacokinetic are assessed.

.

 Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers@highlight

Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend(R) IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers